'Life-changing' ketamine-derived depression treatment to become more affordable for Australians
A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more affordable for 30,000 Australians. The medication is a chemical cousin of the drug ketamine and is bringing hope to many who live with the chronic mental illness.
SBS News In Depth · SBS Audio
April 28, 20256m 55s
Audio is streamed directly from the publisher (sbs-podcast.streamguys1.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more affordable for 30,000 Australians. The medication is a chemical cousin of the drug ketamine and is bringing hope to many who live with the chronic mental illness.